These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 25546932)
1. [Therapeutic value of lymphadenectomy in ovarian cancer patients]. Gmyrek L; Jońska-Gmyrek J; Żółciak-Siwińska A Ginekol Pol; 2014 Oct; 85(10):788-91. PubMed ID: 25546932 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging. Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114 [TBL] [Abstract][Full Text] [Related]
3. Regional variation in surgical assessment of lymph nodes for staging among women with early-stage epithelial ovarian cancer. Ulanday KT; Ward KK; Macera CA; Ji M; Plaxe SC Gynecol Oncol; 2014 Feb; 132(2):411-5. PubMed ID: 24246773 [TBL] [Abstract][Full Text] [Related]
4. Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validation. Pereira A; Irishina N; Pérez-Medina T; Magrina JF; Magtibay PM; Kovaleva A; Rodríguez-Tapia A; Iglesias E Eur J Surg Oncol; 2013 Mar; 39(3):290-6. PubMed ID: 23290581 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis. Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935 [TBL] [Abstract][Full Text] [Related]
6. Transdiaphragmatic cardiophrenic lymph node resection for Stage IV ovarian cancer. LaFargue CJ; Bristow RE Gynecol Oncol; 2015 Sep; 138(3):762-3. PubMed ID: 26049122 [No Abstract] [Full Text] [Related]
7. [Therapeutic and prognostic value of lymphadenectomy in gynecological oncology]. Perzyło K; Miotła P; Lis E; Rechberger T Ginekol Pol; 2013 Jul; 84(7):630-6. PubMed ID: 24032276 [TBL] [Abstract][Full Text] [Related]
8. Is lymphadenectomy necessary in mucinous ovarian cancer? A single institution experience. Salgado-Ceballos I; Ríos J; Pérez-Montiel D; Gallardo L; Barquet-Muñoz S; Salcedo-Hernández R; Pérez-Plasencia C; Herrera LA; Cantú de León DF Int J Surg; 2017 May; 41():1-5. PubMed ID: 28315410 [TBL] [Abstract][Full Text] [Related]
9. The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer. Bachmann C; Brucker SY; Kraemer B; Rothmund R; Staebler A; Fend F; Wallwiener D; Grischke EM J Cancer Res Clin Oncol; 2015 Aug; 141(8):1475-80. PubMed ID: 25739827 [TBL] [Abstract][Full Text] [Related]
10. The effect of lymphadenectomy in advanced ovarian cancer according to residual tumor status: A population-based study. Zhou J; Zhang WW; Zhang QH; He ZY; Sun JY; Chen QH; Wu SG Int J Surg; 2018 Apr; 52():11-15. PubMed ID: 29432972 [TBL] [Abstract][Full Text] [Related]
11. Does debulking of enlarged positive lymph nodes improve survival in different gynaecological cancers? Somashekhar SP Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):870-83. PubMed ID: 26043964 [TBL] [Abstract][Full Text] [Related]
12. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer. Cowan RA; Tseng J; Murthy V; Srivastava R; Long Roche KC; Zivanovic O; Gardner GJ; Chi DS; Park BJ; Sonoda Y Gynecol Oncol; 2017 Nov; 147(2):262-266. PubMed ID: 28888540 [TBL] [Abstract][Full Text] [Related]
13. Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature. Desteli GA; Gultekin M; Usubutun A; Yuce K; Ayhan A World J Surg Oncol; 2010 Nov; 8():106. PubMed ID: 21114870 [TBL] [Abstract][Full Text] [Related]
14. The safety and feasibility of robotic-assisted lymph node staging in early-stage ovarian cancer. Brown JV; Mendivil AA; Abaid LN; Rettenmaier MA; Micha JP; Wabe MA; Goldstein BH Int J Gynecol Cancer; 2014 Oct; 24(8):1493-8. PubMed ID: 25078341 [TBL] [Abstract][Full Text] [Related]
15. Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study. Signorelli M; Guerra L; Pirovano C; Crivellaro C; Fruscio R; Buda A; Cuzzucrea M; Elisei F; Ceppi L; Messa C Gynecol Oncol; 2013 Nov; 131(2):395-9. PubMed ID: 23988414 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer. Ataseven B; Grimm C; Harter P; Prader S; Traut A; Heitz F; du Bois A Gynecol Oncol; 2014 Dec; 135(3):435-40. PubMed ID: 25312398 [TBL] [Abstract][Full Text] [Related]
17. Lymphadenectomy in surgical stage I epithelial ovarian cancer. Svolgaard O; Lidegaard O; Nielsen ML; Nedergaard L; Mosgaard BJ; Lidang M; Mogensen O; Kock K; Blaakaer J; Staehr E; Andersen ES; Grove A; Høgdall C Acta Obstet Gynecol Scand; 2014 Mar; 93(3):256-60. PubMed ID: 24447203 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer. Gouy S; Goetgheluck J; Uzan C; Duclos J; Duvillard P; Morice P Eur J Surg Oncol; 2012 Feb; 38(2):170-5. PubMed ID: 22104389 [TBL] [Abstract][Full Text] [Related]